Opaleye Management Inc. Harrow Health, Inc. Put Options Transaction History
Opaleye Management Inc.
- $411 Million
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding HROW
# of Institutions
124Shares Held
21.3MCall Options Held
113KPut Options Held
366K-
Private Capital Management, LLC Naples, FL3.01MShares$62.8 Million4.93% of portfolio
-
Black Rock Inc. New York, NY2.18MShares$45.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$38.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY953KShares$19.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA694KShares$14.5 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $564M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...